Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease-Reference-Cited by-同舟云学术

Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease

Published:2018-09-25 Issue:13 Volume:138 Page:1290-1300
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Orme Rachel C.¹²,Parker William A.E.¹²,Thomas Mark R.¹²³,Judge Heather M.¹,Baster Kathleen⁴,Sumaya Wael¹²,Morgan Kenneth P.²,McMellon Hannah C.¹²,Richardson James D.²,Grech Ever D.²,Wheeldon Nigel M.²,Hall Ian R.²,Iqbal Javaid¹²,Barmby David²,Gunn Julian P.¹²,Storey Robert F.¹²,Wilcox (chair) Robert G.,Walsh John T.,Smith William,Skene Allan

Affiliation:

1. Department of Infection, Immunity and Cardiovascular Disease (R.C.O., W.A.E.P., M.R.T., H.M.J., W.S., H.C.M., J.I., J.P.G., R.F.S.), University of Sheffield, United Kingdom.

2. Sheffield Teaching Hospitals National Health Service Foundation Trust, United Kingdom (R.C.O., W.A.E.P., M.R.T., W.S., K.P.M., H.C.M., J.D.R., E.D.G., N.M.W., I.R.H., J.I., D.B., J.P.G., R.F.S).

3. University of Birmingham, United Kingdom (M.R.T.).

4. Statistical Services Unit, (K.B.), University of Sheffield, United Kingdom.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference32 articles.

1. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

2. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

3. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).;Valgimigli M;Eur Heart J,2018

4. Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus

5. Development and Clinical use of Prasugrel and Ticagrelor

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic coronary syndromes: diagnosis, management and gaps in evidence;Heart, Vessels and Transplantation;2024-08-28

2. Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation;Expert Review of Cardiovascular Therapy;2024-07

3. P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study;JACC: Cardiovascular Interventions;2024-04

4. TICAGRELOR - MECHANISM OF ACTION AND ITS IMPACT ON DRUG EFFICACY;FARMACIA;2024

5. Comparison of clopidogrel and ticagrelor in treating acute coronary syndrome undergoing PCI: A systematic review and meta-analysis;Heliyon;2024-03